aid: cerevasc
name: CereVasc
description: 'CereVasc, Inc. is a clinical-stage medical device company developing
  novel, minimally invasive treatments for patients with neurological diseases. Its
  lead product, the eShunt System, uses percutaneous transvenous-transdural access
  to the central nervous system to treat communicating hydrocephalus — including normal
  pressure hydrocephalus (NPH) — as a less invasive alternative to conventional
  neurosurgical shunt placement. The eShunt System is an investigational device
  limited by United States federal law to investigational use, and is being evaluated
  in the STRIDE pivotal study (NCT06498960). CereVasc raised a $70M Series B in 2024
  and has received FDA Breakthrough Device Designation. The company builds implantable
  hardware and publishes no public API, developer program, or machine-readable
  specification.'
url: https://raw.githubusercontent.com/api-evangelist/cerevasc/refs/heads/main/apis.yml
image: https://cerevasc.com/wp-content/uploads/2023/10/CereVasc-logo-%C2%AEweb-main.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-09'
modified: '2026-08-09'
tags:
- Company
- Medical Devices
- Healthcare
- Neurology
- Hydrocephalus
- Medical Technology
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cerevasc-domain-security.yml
- type: Website
  url: https://cerevasc.com/
- type: About
  url: https://cerevasc.com/eshunt-system-cerevasc/
- type: Contact
  url: https://cerevasc.com/contact-cerevasc/
- type: Blog
  url: https://cerevasc.com/press/
- type: BlogRSS
  url: https://cerevasc.com/feed/
- type: PrivacyPolicy
  url: https://cerevasc.com/privacy-policy/
- type: SecondaryMarketListing
  url: https://forgeglobal.com/cerevasc_stock/
x-enrichment:
  date: '2026-08-09'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    CereVasc is a clinical-stage neurovascular implant maker whose product is the
    physical eShunt device; its WordPress site has no /developers, /api or /docs
    path, no api./developer./docs. subdomain resolves in DNS, and every discovery
    probe (/openapi.json, /llms.txt, /.well-known/agent-card.json) returned 404.
  evidence:
    - url: https://cerevasc.com/openapi.json
      status: 404
    - url: https://cerevasc.com/developers
      status: 404
    - url: https://cerevasc.com/llms.txt
      status: 404
    - url: https://cerevasc.com/.well-known/agent-card.json
      status: 404
    - url: https://cerevasc.com/.well-known/security.txt
      status: 404
    - url: https://cerevasc.com/
      status: 200
  checked: '2026-08-09'